^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

B2M elevation

i
Entrez ID:
Phase 2
ImaginAb, Inc.
Completed
Last update posted :
02/13/2020
Initiation :
01/01/2015
Primary completion :
04/01/2016
Completion :
07/01/2016
FOLH1
|
B2M elevation • FOLH1 expression
|
177Lu-capromab pendetide (CYT 500)